Reversal of ABCB1- and ABCG2-mediated MDR byerlotinib (tarceva, OSI-774)
Year: 2008
Type: article
Source: Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1515774185
